792 Natural killer T cell immunotherapy combined with fusogenic oncolytic virus and PD-1 blockade enhances survival in a mouse model of spontaneous lung adenocarcinoma
Abstract:Background Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, with a 5-year survival rate of 19%. Improvements in treatment are crucial for reducing both morbidity and mortality. In this study, we examined the therapeutic benefit of combining oncolytic vesicular stomatitis virus (VSV) expressing reovirus-derived fusion-associated small transmembrane (FAST) proteins (p14 or p15), PD-1 checkpoint blockade, and natural killer T (NKT) cell immunotherapy in a genetic mouse model of lung adenoca… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.